Impact Factor 4.848 | CiteScore 3.5
More on impact ›

Correction ARTICLE

Front. Oncol., 20 November 2020 | https://doi.org/10.3389/fonc.2020.617539

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

Xiaoyi Hu1,2,3,4†, Mingyang Bao5†, Jiacheng Huang1,2,3,4, Lin Zhou2,3,4* and Shusen Zheng1,2,3,4*
  • 1Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
  • 2National Health and Family Planning Commission of China Key Laboratory of Combined Multi-Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
  • 3Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences, Hangzhou, China
  • 4Key Laboratory of Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
  • 5State Key Laboratory of Genetic Engineering, School of Life Sciences, Institute of Biostatistics, Fudan University, Shanghai, China

A Corrigendum On
Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma

by Hu X, Bao M, Huang J, Zhou L and Zheng S (2020). Front. Oncol. 10:541479. doi: 10.3389/fonc.2020.541479

In the published article, there was an error in affiliation 2, “State Key Laboratory of Genetic Engineering, School of Life Sciences, Institute of Biostatistics, Fudan University, Shanghai, China.” Instead of affiliation 2, it should be affiliation 5.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: prognosis, biomarker, GEO, hepatocellular carcinoma (HCC), diagnosis

Citation: Hu X, Bao M, Huang J, Zhou L and Zheng S (2020) Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma. Front. Oncol. 10:617539. doi: 10.3389/fonc.2020.617539

Received: 15 October 2020; Accepted: 16 October 2020;
Published: 20 November 2020.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2020 Hu, Bao, Huang, Zhou and Zheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lin Zhou, zhoulin99@zju.edu.cn; Shusen Zheng, shusenzheng@zju.edu.cn

These authors have contributed equally to this work